2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 178484095, compound

HRID 2271746Notes

Reaction equation

HRID 2271746 reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C@H:18]1[CH2:23][CH2:22][C@H:21]([N:24]([CH3:26])[CH3:25])[CH2:20][CH2:19]1.[Cl:27][C:28]1[CH:33]=[C:32](B2OC(C)(C)C(C)(C)O2)[CH:31]=[C:30]([Cl:43])[C:29]=1[OH:44]>>[CH:14]1([C:12]([C:6]2[CH:7]=[N:8][C:9]3[C:4]([C:5]=2[NH:17][C@H:18]2[CH2:23][CH2:22][C@H:21]([N:24]([CH3:25])[CH3:26])[CH2:20][CH2:19]2)=[CH:3][C:2]([C:32]2[CH:33]=[C:28]([Cl:27])[C:29]([OH:44])=[C:30]([Cl:43])[CH:31]=2)=[CH:11][CH:10]=3)=[O:13])[CH2:15][CH2:16]1

Participants

3

Procedure

Following general procedure F, {6-bromo-4-[trans-4-(dimethylamino)cyclohexylamino]quinolin-3-yl}(cyclopropyl)methanone (45 mg, 0.110 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (38 mg, 0.135 mmol) to afford the desired product (32 mg, 58%) as a light yellow solid: NMR (500 MHz, CD3OD) δ 9.30 (s, 1H), 8.50 (s, 1H), 8.28 (d, J=8.8 Hz, 1H), 8.00 (d, J=8.8 Hz, 1H), 7.78 (s, 2H), 4.47 (s, 1H), 3.45 (s, 1H), 2.91 (s, 6H), 2.85 (s, 1H), 2.51 (s, 2H), 2.31 (s, 2H), 1.91-1.74 (m, 4H), 1.31-1.18 (m, 4H); ESI MS m/z 498 [C27H29Cl2N3O2+H]+; HPLC 96.9% (AUC), tR=11.50 min.

Sources & evidence

ORD record
ord-f8b5a15ab9b341aab3ccadfe58a2ab7c
Source dataset
uspto-grants-2015_09
Patent number
US09120749B2

Reaction notes

Loading…